Cargando…
Combination Therapy for Chronic Hepatitis B: Current Indications
Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several therapeutic agents active against viral and host targets are currently available for its treatment. The success of combination therapy in HIV infection...
Autores principales: | Paul, Navin, Han, Steven-Huy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085106/ https://www.ncbi.nlm.nih.gov/pubmed/21654909 http://dx.doi.org/10.1007/s11901-011-0095-1 |
Ejemplares similares
-
Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
por: Su, Tung-Hung, et al.
Publicado: (2017) -
Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004) -
Current Trend in Antiviral Therapy for Chronic Hepatitis B
por: Chien, Rong-Nan, et al.
Publicado: (2022) -
A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B
por: Khungar, Vandana, et al.
Publicado: (2010) -
Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011)